AVDL — Avadel Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapSucker Stock

Annual balance sheet for Avadel Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	223	157	96.5	105	73.8
Net Total Accounts Receivable
Net Total Receivables	39.1	31.8	2.59	13.4	34.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	263	192	101	134	134
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.96	2.94	2.55	3.18	2.15
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	312	247	133	165	164
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	15.1	21	55.8	36.9	48.8
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	149	169	154	77	90.4
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	162	78.2	-21.1	87.7	73.8
Total Liabilities & Shareholders' Equity	312	247	133	165	164
Total Common Shares Outstanding
Total Preferred Shares Outstanding